Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.

To compare the breast cancer-specific survival (BCSS) between patients who underwent tissue or implant reconstruction after mastectomy.We used the database from Surveillance, Epidemiology, and End Results (SEER) registries and compared the BCSS between patients who underwent tissue and implant recon...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Authors: Qian Ouyang, Liling Zhu, Kai Chen, Fengxi Su
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Online Access:http://europepmc.org/articles/PMC4334889?pdf=render
_version_ 1852786285439090688
author Qian Ouyang
Liling Zhu
Kai Chen
Fengxi Su
author_facet Qian Ouyang
Liling Zhu
Kai Chen
Fengxi Su
author_sort Qian Ouyang
collection DOAJ
container_title PLoS ONE
description To compare the breast cancer-specific survival (BCSS) between patients who underwent tissue or implant reconstruction after mastectomy.We used the database from Surveillance, Epidemiology, and End Results (SEER) registries and compared the BCSS between patients who underwent tissue and implant reconstruction after mastectomy. Cox-regression models were fitted, adjusting for known clinicopathological features. The interaction between the reconstruction types (tissue/implant) and nodal status (N-stage) was investigated.A total of 6,426 patients with a median age of 50 years were included. With a median follow up of 100 months, the 10-year cumulative BCSS and non-BCSS were 85.1% and 95.4%, respectively. Patients who underwent tissue reconstruction had tumors with a higher T-stage, N-stage, and tumor grade and tended to be ER/PR-negative compared to those who received implant reconstruction. In univariate analysis, implant-reconstruction was associated with a 2.4% increase (P = 0.003) in the BCSS compared with tissue-reconstruction. After adjusting for significant risk factors of the BCSS (suggested by univariate analysis) and stratifying based on the N-stage, there was only an association between the reconstruction type and the BCSS for the N2-3 patients (10-year BCSS of implant vs. tissue-reconstruction: 68.7% and 59.0%, P = 0.004). The 10-year BCSS rates of implant vs. tissue-reconstruction were 91.7% and 91.8% in N0 patients (P>0.05) and 84.5% and 84.4% in N1 patients (P>0.05), respectively.The implant (vs. tissue) reconstruction after mastectomy was associated with an improved BCSS in N2-3 breast cancer patients but not in N0-1 patients. A well-designed, prospective study is needed to further confirm these findings.
format Article
id doaj-art-00a45102faa74be28f0f4964b63fc87c
institution Directory of Open Access Journals
issn 1932-6203
language English
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
spelling doaj-art-00a45102faa74be28f0f4964b63fc87c2025-08-19T20:45:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01102e011816110.1371/journal.pone.0118161Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.Qian OuyangLiling ZhuKai ChenFengxi SuTo compare the breast cancer-specific survival (BCSS) between patients who underwent tissue or implant reconstruction after mastectomy.We used the database from Surveillance, Epidemiology, and End Results (SEER) registries and compared the BCSS between patients who underwent tissue and implant reconstruction after mastectomy. Cox-regression models were fitted, adjusting for known clinicopathological features. The interaction between the reconstruction types (tissue/implant) and nodal status (N-stage) was investigated.A total of 6,426 patients with a median age of 50 years were included. With a median follow up of 100 months, the 10-year cumulative BCSS and non-BCSS were 85.1% and 95.4%, respectively. Patients who underwent tissue reconstruction had tumors with a higher T-stage, N-stage, and tumor grade and tended to be ER/PR-negative compared to those who received implant reconstruction. In univariate analysis, implant-reconstruction was associated with a 2.4% increase (P = 0.003) in the BCSS compared with tissue-reconstruction. After adjusting for significant risk factors of the BCSS (suggested by univariate analysis) and stratifying based on the N-stage, there was only an association between the reconstruction type and the BCSS for the N2-3 patients (10-year BCSS of implant vs. tissue-reconstruction: 68.7% and 59.0%, P = 0.004). The 10-year BCSS rates of implant vs. tissue-reconstruction were 91.7% and 91.8% in N0 patients (P>0.05) and 84.5% and 84.4% in N1 patients (P>0.05), respectively.The implant (vs. tissue) reconstruction after mastectomy was associated with an improved BCSS in N2-3 breast cancer patients but not in N0-1 patients. A well-designed, prospective study is needed to further confirm these findings.http://europepmc.org/articles/PMC4334889?pdf=render
spellingShingle Qian Ouyang
Liling Zhu
Kai Chen
Fengxi Su
Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.
title Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.
title_full Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.
title_fullStr Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.
title_full_unstemmed Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.
title_short Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.
title_sort effect of implant vs tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients
url http://europepmc.org/articles/PMC4334889?pdf=render
work_keys_str_mv AT qianouyang effectofimplantvstissuereconstructiononcancerspecificsurvivalvariesbyaxillarylymphnodestatusinbreastcancerpatients
AT lilingzhu effectofimplantvstissuereconstructiononcancerspecificsurvivalvariesbyaxillarylymphnodestatusinbreastcancerpatients
AT kaichen effectofimplantvstissuereconstructiononcancerspecificsurvivalvariesbyaxillarylymphnodestatusinbreastcancerpatients
AT fengxisu effectofimplantvstissuereconstructiononcancerspecificsurvivalvariesbyaxillarylymphnodestatusinbreastcancerpatients